Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ZM2S
|
|||
| Former ID |
DIB009219
|
|||
| Drug Name |
R1204
|
|||
| Indication | Depression [ICD-11: 6A70-6A7Z; ICD-9: 311] | Discontinued in Phase 1 | [1] | |
| Company |
Roche
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H14O
|
|||
| Canonical SMILES |
CC1=CC(=C(C(=C1)C)C(=O)C)C
|
|||
| InChI |
1S/C11H14O/c1-7-5-8(2)11(10(4)12)9(3)6-7/h5-6H,1-4H3
|
|||
| InChIKey |
XWCIICLTKWRWCI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1667-01-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GPCR unspecific (GPCR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017253) | |||
| REF 2 | Clinical pipeline report, company report or official report of Roche. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.